Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 12 2020
Historique:
received: 06 07 2020
accepted: 08 10 2020
pubmed: 1 11 2020
medline: 22 12 2020
entrez: 31 10 2020
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infections often cause only mild disease that may evoke relatively low Ab titers compared with patients admitted to hospitals. Generally, total Ab bridging assays combine good sensitivity with high specificity. Therefore, we developed sensitive total Ab bridging assays for detection of SARS-CoV-2 Abs to the receptor-binding domain (RBD) and nucleocapsid protein in addition to conventional isotype-specific assays. Ab kinetics was assessed in PCR-confirmed, hospitalized coronavirus disease 2019 (COVID-19) patients (

Identifiants

pubmed: 33127820
pii: jimmunol.2000767
doi: 10.4049/jimmunol.2000767
doi:

Substances chimiques

Antibodies, Viral 0
Nucleocapsid Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3491-3499

Investigateurs

Robert Hemke (R)
Diederik van de Beek (D)
Martijn Beudel (M)
Matthijs C Brouwer (MC)
Bart Geerts (B)
Markus Hollmann (M)
Bennedikt Preckel (B)
Denise Veelo (D)
A H Koos Zwinderman (AHK)
Theo Geijtenbeek (T)
Florianne Hafkamp (F)
Diane Bax (D)
Alex Cloherty (A)
Michiel van Agtmael (M)
Marije Bomers (M)
Suzanne Geerlings (S)
Martin P Grobusch (MP)
Vanessa Harris (V)
Sabine M Hermans (SM)
Joppe W Hovius (JW)
Jeaninne Nellen (J)
Edgar Peters (E)
Tom van der Poll (T)
Jan M Prins (JM)
Kim Sigaloff (K)
Cornelis S Stijnis (CS)
Marc van der Valk (M)
Michèle van Vugt (M)
W Joost Wiersinga (WJ)
Godelieve Bree (G)
Alexander P J Vlaar (APJ)
Sanne de Bruin (S)
Anne Geke Algera (AG)
Frank van Baarle (F)
Lieuwe Bos (L)
Michela Botta (M)
Esther Bulle (E)
Paul Elbers (P)
Lucas Fleuren (L)
Armand Girbes (A)
Laura Hagens (L)
Leo Heunks (L)
Janneke Horn (J)
Mourik van Mourik (M)
Frederique Paulus (F)
Jorinde Raasveld (J)
Marcus Schultz (M)
Marry Smit (M)
Willemke Stilma (W)
Patrick Thoral (P)
Anissa Tsonas (A)
Heder de Vries (H)
Alex Schuurmans (A)
Menno de Jong (M)
Marianna Bugiani (M)
Harm Jan Bogaard (HJ)
Charlotte Teunissen (C)
Jorg Hamann (J)

Informations de copyright

Copyright © 2020 by The American Association of Immunologists, Inc.

Auteurs

Erik H Vogelzang (EH)

Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Reade, Amsterdam, the Netherlands.
Department of Medical Microbiology and Infection Control, Amsterdam University Medical Center, Location Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.

Floris C Loeff (FC)

Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.
Biologics Laboratory, Sanquin Diagnostic Services, 1066 CX Amsterdam, the Netherlands.

Ninotska I L Derksen (NIL)

Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

Simone Kruithof (S)

Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

Pleuni Ooijevaar-de Heer (P)

Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

Gerard van Mierlo (G)

Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

Federica Linty (F)

Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

Juk Yee Mok (JY)

Sanquin Reagents, 1066 CX Amsterdam, the Netherlands.

Wim van Esch (W)

Sanquin Reagents, 1066 CX Amsterdam, the Netherlands.

Sanne de Bruin (S)

Department of Intensive Care Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.

Alexander P J Vlaar (APJ)

Department of Intensive Care Medicine, Amsterdam University Medical Center, Location Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.

Bart Seppen (B)

Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Reade, Amsterdam, the Netherlands.

Maureen Leeuw (M)

Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Reade, Amsterdam, the Netherlands.

Anne J G van Oudheusden (AJG)

Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, 5042 AD Tilburg, the Netherlands.

Anton G M Buiting (AGM)

Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, 5042 AD Tilburg, the Netherlands.

Kin Ki Jim (KK)

Department of Medical Microbiology and Infection Control, Amsterdam University Medical Center, Location Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.
Departments of Medical Microbiology, Jeroen Bosch Hospital, 5223 GZ 's Hertogenbosch, the Netherlands.

Hans Vrielink (H)

Department of Transfusion Medicine, Sanquin Blood Bank, 1066 CX Amsterdam, the Netherlands.

Francis Swaneveld (F)

Department of Transfusion Medicine, Sanquin Blood Bank, 1066 CX Amsterdam, the Netherlands.

Gestur Vidarsson (G)

Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

C Ellen van der Schoot (CE)

Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.

Peter C Wever (PC)

Departments of Medical Microbiology, Jeroen Bosch Hospital, 5223 GZ 's Hertogenbosch, the Netherlands.

Wentao Li (W)

Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; and.

Frank van Kuppeveld (F)

Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; and.

Jean-Luc Murk (JL)

Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, 5042 AD Tilburg, the Netherlands.

Berend Jan Bosch (BJ)

Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; and.

Gerrit-Jan Wolbink (GJ)

Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, 1056 AB Reade, Amsterdam, the Netherlands.
Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands.
Department of Rheumatology, OLVG Hospital, 1091 AC Amsterdam, the Netherlands.

Theo Rispens (T)

Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, 1066 CX Amsterdam, the Netherlands; t.rispens@sanquin.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH